The 12 references in paper A. Lozhkov A., A. Vazhenin V., T. Sharabura M., A. Aladin S., A. Zhumabayeva G., A. Turbina V., E. Mozerova, O. Davydova N., А. Ложков А., А. Важенин В., Т. Шарабура М., А. Аладин С., А. Жумабаева Г., А. Турбина В., Е. Мозерова Я., О. Давыдова Н. (2015) “НЕПОСРЕДСТВЕННЫЕ РЕЗУЛЬТАТЫ КОНФОРМНОЙ HDR-БРАХИТЕРАПИИ ОПУХОЛЕЙ СЛИЗИСТОЙ ОБОЛОЧКИ ПОЛОСТИ РТА НА АППАРАТЕ MULTISOURCE // IMMEDIATE RESULTS OF CONFORMIC HDR BRACHYTHERAPY USING THE MULTISOURCE APPARATUS FOR ORAL MUCOSAL TUMORS” / spz:neicon:ogsh:y:2012:i:1:p:9-13

1
Пачес А.И. Опухоли головы и шеи. Медицина, 2000. C. 416.
(check this in PDF content)
2
Mazeron J.-J., Noel G., Simon J.-M. Head and neck brachytherapy. Semin Radiat Oncol 2002 Jan;12(1):95–108.
(check this in PDF content)
3
Inoue T., Inoue T., Yoshida K., Yoshioka Y. Phase III trial of high- vs. lowdose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys 2001 Sep;51(1):171–5.
(check this in PDF content)
4
Kakimoto N., Inoue T., Inoue T., Murakami S. et al. Results of low- and highdose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiother Oncol 2003;68(2):123–8.
(check this in PDF content)
5
Mazeron J.-J., Ardiet J.-M., Haie-Méder C., Kovács G., Levendag P., Peiffert D., Polo A., Rovirosa A., Strnad V. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 2009 May; 91(2):150–6.
(check this in PDF content)
6
Palmer A., Mzenda B. Does the choice of isotope, Co60 or Ir192, affect treatment planning techniques and outcomes for high dose rate (HDR) brachytherapy? Portsmouth Hospitals NHS Trust, Portsmouth, UK. Int J Radiat Oncol Biol Phys 2010;78:3.
(check this in PDF content)
7
Do L., Puthawala A., Syed N. et al. Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer. Brachytherapy 2009 Oct–Dec;8(4):385–91.
(check this in PDF content)
8
Pellizzon A.C., dos Santos Novaes P.E. et al. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer. Head Neck 2005 Dec;27(12):1035–41.
(check this in PDF content)
9
Guinot J.L., Santos M., Tortajada M.I. et al. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma. Brachytherapy 2010 Jul–Sep; 9(3):227–34.
(check this in PDF content)
10
Patton B., Hu K., Perksy M., Urken M. et al. Survival and toxicity outcomes in base of tongue cancer treated with brachytherapy boost combined with 2D or IMRT: a ten year experience. Int J Radiat Oncol Biol Phys 2010;78(3):S61.
(check this in PDF content)
11
Patra N.B., Goswami J., Basu S. et al. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer — an Indian (single institutional) learning experience. Brachytherapy 2009 Apr—June;8(2):248–54.
(check this in PDF content)
12
Sresty N.V., Ramanjappa T. et al. Acquisition of equal or better planning results with interstitial brachytherapy when compared with intensity-modulated radiotherapy in tongue cancers.
(check this in PDF content)